Avitar Net Income 1971-1970 | AVTI

Avitar net income from 1971 to 1970. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Avitar Annual Net Income
(Millions of US $)
Avitar Quarterly Net Income
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
Avitar, Inc. (Avitar), through its wholly owned subsidiary Avitar Technologies, Inc. (ATI), develops, manufactures, markets and sells diagnostic test products and hydrophilic polyurethane foam disposables fabricated for medical, diagnostics, dental and consumer use. The Company continued the development and marketing of point-of-care oral fluid drugs of abuse tests, which use the Company's foam as the means for collecting the oral fluid sample. Avitar sells its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies and corporations. The Company continues to have applications for its technologies in a variety of other medical/consumer markets. They include a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. Customers for these products include ArthroCare and National Aeronautics and Space Administration (NASA).
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.606B 24.25
Becton Dickinson (BDX) United States $47.863B 11.85
Cardinal Health (CAH) United States $36.277B 19.00
Labcorp (LH) United States $20.659B 16.76
Straumann Holding AG (SAUHY) Switzerland $19.996B 0.00
Cooper (COO) United States $16.312B 21.64
West Pharmaceutical Services (WST) United States $15.158B 31.77
Align Technology (ALGN) United States $13.003B 25.56
Henry Schein (HSIC) United States $8.157B 13.90
Merit Medical Systems (MMSI) United States $5.552B 26.84
DENTSPLY SIRONA (XRAY) United States $2.758B 8.29
CONMED (CNMD) United States $1.763B 13.19
STAAR Surgical (STAA) United States $0.940B 0.00
Lifevantage (LFVN) United States $0.148B 16.36
Pro-Dex (PDEX) United States $0.147B 16.05